ECALLANTIDE for Immune system disorder: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 132 adverse event reports in the FDA FAERS database where ECALLANTIDE was used for Immune system disorder.
Most Reported Side Effects for ECALLANTIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hereditary angioedema | 519 | 43.0% | 8 | 335 |
| Off label use | 139 | 11.5% | 1 | 56 |
| Drug ineffective | 89 | 7.4% | 1 | 53 |
| Malaise | 60 | 5.0% | 1 | 28 |
| Product dose omission issue | 57 | 4.7% | 1 | 38 |
| Headache | 54 | 4.5% | 1 | 21 |
| Weight decreased | 52 | 4.3% | 0 | 38 |
| Pain | 50 | 4.2% | 1 | 19 |
| Weight increased | 47 | 3.9% | 0 | 32 |
| Hypersensitivity | 38 | 3.2% | 0 | 14 |
| Inappropriate schedule of product administration | 38 | 3.2% | 2 | 21 |
| Nausea | 38 | 3.2% | 0 | 15 |
| Therapeutic response decreased | 38 | 3.2% | 0 | 21 |
| Urticaria | 38 | 3.2% | 0 | 8 |
| Covid-19 | 36 | 3.0% | 1 | 26 |
Other Indications for ECALLANTIDE
Hereditary angioedema (980)
Product used for unknown indication (102)
Angioedema (13)
Immunodeficiency common variable (7)
Hereditary angioedema with normal c1 esterase inhibitor (6)
Idiopathic angioedema (6)
Asthma (5)
Other Drugs Used for Immune system disorder
LANADELUMAB (1,047)
ICATIBANT (847)
HUMAN IMMUNOGLOBULIN G (508)
HUMAN C1-ESTERASE INHIBITOR (387)
LANADELUMAB-FLYO (327)
RITUXIMAB (77)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (51)
LENALIDOMIDE (46)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (35)
RUXOLITINIB (35)